Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Houston, Texas


Purpose:

The purpose of this study is to evaluate the effects (good and bad) of LY231514 (ALIMTA) and Carboplatin on you and your non-small cell lung cancer.


Criteria:

Inclusion Criteria: - You have a diagnosis of non-small cell lung cancer. - You have received no prior chemotherapy. - You have at least one measurable lesion. - You have an adequate performance status. - You are at least 18 years of age. Exclusion Criteria: - You have previously received chemotherapy for your lung cancer. - You have received radiation within the last 30 days. - You have active infection or other serious condition. - You have brain metastasis. - You have recently lost a significant amount of weight.


NCT ID:

NCT00051493


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Houston, Texas
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: June 25, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.